{"organizations": [], "uuid": "d3c9579b7dbda23179a7d4e114e0b30cd2eb2ce0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 35, "shares": 35, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://images.wsj.net/im-2212/social", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/roche-to-acquire-healthcare-software-company-flatiron-for-1-9-billion-1518732811", "country": "US", "domain_rank": 387, "title": "Roche to Acquire Healthcare-Software Company Flatiron for $1.9 Billion", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.59, "site_type": "news", "published": "2018-02-16T01:13:00.000+02:00", "replies_count": 0, "uuid": "d3c9579b7dbda23179a7d4e114e0b30cd2eb2ce0"}, "author": "Aisha Al-Muslim", "url": "https://www.wsj.com/articles/roche-to-acquire-healthcare-software-company-flatiron-for-1-9-billion-1518732811", "ord_in_thread": 0, "title": "Roche to Acquire Healthcare-Software Company Flatiron for $1.9 Billion", "locations": [], "entities": {"persons": [], "locations": [{"name": "flatiro", "sentiment": "none"}], "organizations": [{"name": "roche to acquire healthcare-software company flatiron", "sentiment": "negative"}, {"name": "billion pharmaceuticals", "sentiment": "negative"}, {"name": "roche holding ag", "sentiment": "negative"}, {"name": "new york city-based flatiron health", "sentiment": "none"}, {"name": "roche", "sentiment": "none"}, {"name": "n health inc.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Pharmaceuticals firm Roche Holding AG has agreed to buy the shares it doesnâ€™t already own of Flatiron Health Inc., an oncology software company, for $1.9 billion, the companies said Thursday.\nSwitzerland-based Roche said the deal is part of an effort to accelerate its development and delivery of medicines for cancer patients. Roche already owns 12.6% of New York City-based Flatiron Health, which was launched in 2012.\n\nThe... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-02-16T01:13:00.000+02:00", "crawled": "2018-02-16T01:50:50.007+02:00", "highlightTitle": ""}